Physician

Ageliki S. Valsamis, D.O.

According to 2025 Medicare claims, Ageliki Valsamis, D.O. (NPI: 1558329730) practices endocrinology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Nassau, NY. This provider's primary affiliated billing organization is NORTH SHORE-LIJ MEDICAL PC (NPI: 1053688572; TIN: 113506359) and primary practice location at 11710-5555. Valsamis is affiliated with the Northwell Health ACO (ACO ID: A3030), participating under the MSSP model.

Valsamis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 390 traditional Medicare patients, billed 8,751 HCPCS/CPT codes, and received $240,805 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 4,404 prescription claims across 446 beneficiaries totaling $2,070,302 in drug costs, led by Ozempic (Semaglutide). DME data shows 501 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $49,835 to $240,805. Similarly, Part D prescription costs have moved sharply higher in recent years, from $676,443 to $2,070,302. For DME billing, reported payments moved sharply higher in recent years, from $5,938 to $133,576.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	218	1,188	$49,835
2016	278	1,935	$69,726
2017	304	3,070	$87,078
2018	308	5,103	$122,378
2019	335	5,893	$138,441
2020	310	5,062	$121,822
2021	341	6,817	$180,793
2022	369	8,298	$215,509
2023	400	8,701	$233,529
2024	390	8,751	$240,805

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	239	2,028	$676,443
2016	255	2,323	$764,293
2017	316	2,753	$1,007,592
2018	355	2,994	$1,150,080
2019	357	3,121	$1,240,333
2020	405	3,308	$1,373,145
2021	437	3,776	$1,769,569
2022	468	3,968	$1,964,867
2023	426	4,248	$2,414,572
2024	446	4,404	$2,070,302

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	122	300	$10,719
2016	155	315	$6,669
2017	111	248	$4,137
2018	172	443	$25,634
2019	144	519	$44,736
2020	112	523	$60,985
2021	115	571	$68,269
2022	119	605	$84,788
2023	137	671	$105,060
2024	135	501	$132,939

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	115	185	$155
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	276	432	$105
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	249	341	$14
96372	Injection of drug or substance under skin or into muscle	73	117	$13
83036	Hemoglobin a1c level	141	253	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	339	19,316	$624,869
Mounjaro	Tirzepatide	239	8,706	$313,983
Trulicity	Dulaglutide	130	6,043	$201,425
Jardiance	Empagliflozin	136	9,145	$178,854
Januvia	Sitagliptin Phosphate	77	5,098	$92,303

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	60	289	$120,199
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	N/R	21	$5,879
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	11	11	$2,488
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	46	104	$2,202
A4225	Supplies for external insulin infusion pump, syringe type cartridge, sterile, each	N	N/R	21	$2,032

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Ageliki S. Valsamis, D.O.?

Tedicare shows public-source Medicare data for Ageliki S. Valsamis, D.O. (NPI 1558329730), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ageliki S. Valsamis, D.O. have ACO affiliation data?

Ageliki S. Valsamis, D.O. is shown with ACO affiliation data for Northwell Health ACO (MSSP, ACO ID A3030).

What billing organization is linked to Ageliki S. Valsamis, D.O.?

Ageliki S. Valsamis, D.O. is linked to NORTH SHORE-LIJ MEDICAL PC (billing NPI 1053688572) in the available physician profile data.

Does Ageliki S. Valsamis, D.O. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.